MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE ASSOCIATIONS WITH ANTI-U1 SMALL NUCLEAR RIBONUCLEOPROTEIN ANTIBODY - RELATIONSHIP TO IMMUNOREACTIVITY WITH INDIVIDUAL CONSTITUENT PROTEINS
M. Kuwana et al., MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENE ASSOCIATIONS WITH ANTI-U1 SMALL NUCLEAR RIBONUCLEOPROTEIN ANTIBODY - RELATIONSHIP TO IMMUNOREACTIVITY WITH INDIVIDUAL CONSTITUENT PROTEINS, Arthritis and rheumatism, 38(3), 1995, pp. 396-405
Objective. To better define immunogenetic associations with the anti-U
1 ribonucleoprotein (U1 RNP) autoantibody response. Methods. HLA class
II alleles were determined by genotyping in 49 Japanese rheumatic dis
ease patients with anti-U1 RNP antibody and 43 race-matched healthy co
ntrols. Immunoreactivities to U1 RNP constituent proteins (70K, A, B/B
', and C) were detected by immunoblots using purified HeLa cell Sm ant
igen, and antibody titer was determined by passive hemagglutination as
say. Results. DQB10302 was significantly more frequent in anti-U1 RNP
-positive patients than in controls (43% versus 14%; odds ratio [OR] =
4.6, corrected P = 0.03). All anti-U1 RNP-positive patients had eithe
r a DQB10601, *0602, *0301, *0302, or *0303 allele, which share tyros
ine at position 30, and the amino acid sequence Thr, Arg, Ala, Glu, Le
u, Asp, and Thr at positions 71-77 in the DQB1 beta 1 domain. In contr
ast, one of these alleles was found in 81% of the controls (OR = 24, P
= 0.002). In addition, anti-U1 RNP antibody was associated with uniqu
e DQB10302; DRB1*0401 haplotype. Anti-70K reactivity and antibody tit
er were positively associated with a basic amino acid residue, arginin
e or histidine, at position 13 (DR2 or DR4) and were negatively associ
ated with the amino acid sequence Ile, Leu, Glu, and Bsp at positions
67-70, which was present in some of the DR5-, DR6-, and DR8-associated
alleles, in the DRB1 beta 1 domain. Anti-C reactivity was strongly as
sociated with DR2, particularly with DRB11502. Conclusion. The severa
l shared epitopes located on HLA-DRB1 and DQB1 genes control the anti-
U1 RNP autoantibody response.